CROI 2015 Program and Abstracts

Disclosure Information

Roederer, Mario Self: FlowJo, LLC: Other Rokx, Casper Self: ViiV Healthcare, outside submitted work.: Grants/ grants pending Rourke, Sean Self: AbbVie: Other Ruel, Theodore Institution: University of California, San Francisco: AbbVie: Provision of medicines, equipment, or administrative support; Other: AbbVie Pharmaceuticals (North Chicago, Illinois) provided lopinavir/ritonavir (Aluvia) but had no other role in study design, data accrual and analysis, or abstract preparation Sax, Paul Self: Gilead: Consulting or advisor fee; AbbVie: Consulting or advisor fee; GSK/ViiV: Consulting or advisor fee; Merck: Consulting or advisor fee; BMS: Consulting or advisor fee; Janssen: Consulting or advisor fee Sekaly, Pierre-Rafick Self: Caprion: Consulting or advisor fee Institution: CaseWestern Reserve University: Medimmune: Grants/grants pending; Gilead: Grants/grants pending; Sanofi: Grants/grants pending; Sangamo: Grants/grants pending Siccardi, Marco Self: Janssen: Grants/grants pending; Saye Khoo: Janssen: Grants/grants pending; David Back: Janssen: Grants/grants pending; Andrew Owen: Janssen: Grants/grants pending Sigel, Keith Self: Gilead Sciences: Consulting or advisor fee Sloan, Derek Self: Gilead Sciences, Inc.: Employment Sohn, Annette Institution: amfAR, the Foundation for AIDS Research:ViiV Healthcare: Grants/grants pending; grant to my institution is unrelated to the work under consideration and is for research and training Spagnuolo, Vencenzo Institution: Infectious Diseases Department, San Raffaele Scientific Institute: Bristol Myers Squibb: Grants/grants pending Sterling, Timothy Self: Otsuka: Other: Data safety monitoring board for aTB clinical trial Sulkowski, Mark Self: Achillion, AbbVie, BMS, Gilead, Merck, Janssen: Consulting or advisor fee Institution: Johns Hopkins University: AbbVie, BMS, Gilead, Janssen: Grants/grants pending; Gilead : Fees for participation in the review activities, eg, data monitoring boards, statistical analysis, or end point adjudication committees

Swenson, Eugene Self: Bristol-Myers Squibb: Employment Taiwo, Babafemi

Warszawski, Josiane Self: Parexel: Other;ViiV Healthcare: Other:These disclosure do not concern the current work submitted, and consist in grants via contract with our promotor for pharmacoviligance studies Wherry, E. John Self: Genentech/Roche: Patents(planned, pending, or issued); Surface Oncology: Stock/stock options Whitney, James Self: Gilead: Grants/grants pending Institution: Beth Israel Deaconess Medical Center: Gilead: Grants/grants pending Wohl, David Self: Gilead Sciences: Grants/grants pending; Gilead Sciences: Consulting or advisor fee; Janssen: Consulting or advisor fee Institution: University of North Carolina: Merck: Grants/ grants pending Wong, Alexander Self: Gilead Sciences, Inc.: Consulting or advisor fee;ViiV Healthcare: Consulting or advisor fee; Bristol-Myers Squibb: Consulting or advisor fee; Janssen Pharmaceuticals, Inc.: Consulting or advisor fee; Gilead Sciences, Inc.: Grants/grants pending;ViiV Healthcare: Grants/grants pending Wong, Michael Self: SareptaTherapeutics : Employment Wyles, David Self: BMS: Consulting or advisor fee; AbbVie: Consulting or advisor fee; Gilead: Consulting or advisor fee; Janssen: Consulting or advisor fee; AbbVie, BMS, Gilead, Merck, Vertex Pharmaceuticals,TacereTherapeutics (payable to UC): Grants/grants pending; AbbVie, BMS, Gilead, Janssen: Consulting or advisor fee Institution: UCSD: Gilead, AbbVie, Merck, BMS,Tacere: Grants/grants pending Yee, Ka Lai Self: Merck & Co: Employment Yeh, Wendy Self: Merck & Co., Inc.: Employment Yin, Michael Self: Gilead: Consulting or advisor fee; AbbVie: Consulting or advisor fee

Self: ViiV: Grants/grants pending;ViiV: Consulting or advisor fee; Gilead: Consulting or advisor fee; Pfizer: Grants/grants pending Tang, Winson Self: Sangamo BioSciences: Employment Tazi, Jamal Self: ABIVAX: Consulting or advisor fee Institution: University of Montpellier: Abivax: Grants/grants pending Thompson, Melanie Self: Janssen/TibotecTherapeutics: Fees for participation in the review activities, eg, data monitoring boards, statistical analysis, or end point adjudication committees;ViiV Healthcare: Fees for participation in the review activities, eg, data monitoring boards, statistical analysis, or end point adjudication committees Institution: All are research contracts (not grants). Additional disclosures for institution, AIDS Research Consortium of Atlanta: Pfizer, Inc., Janssen/Tibotec Therapeutics, Merck,TobiraTherapeutics,ViiV Healthcare. All are research contracts. Bristol-Myers Squibb disclosures: Bristol-Myers Squibb is a commercial entity, patenting and developing the drug described within this presentation Tolstrup, Martin Self: Aarhus University has filed a patent on the use of panobinostat in HIV-infected individuals on which I am co- inventor: Patents(planned, pending, or issued) Tomaras, Georgia Institution: Duke University: NIH BMGF: Other van Sighem, Ard Institution: Stichting HIV Monitoring: Gilead Sciences: Grants/grants pending;ViiV Healthcare: Payment directly from commercial firms for lecture(s), including service on speakers’bureaus; Bristol-Myers Squibb: Payment directly from commercial firms for lecture(s), including service on speakers’bureaus van Zyl, Gert Self: AbbVie: Payment for development of education presentations Vandamme, Anne-Mieke Self: AbbVie: Payment for development of education presentations Institution: KULeuven: mecenat program : Other Spouse/partner: ViiV, AbbVie, Gilead: Payment for development of education presentations Vavro, Cindy Self: GlaxoSmithKline: Employment Institution: GlaxoSmithKline: GlaxoSmithKline: Employment

Disclosure Information

655

CROI 2015